A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer by Valentina D. Tarasova, R. Michael Tuttle

Get full text

Radioactive iodine therapy: multiple faces of the same polyhedron by Rosália do Prado Padovani, Sumedha V. Chablani, Robert Michael Tuttle

Get full text

Abnormal growth rate of a benign cervical sympathetic chain schwannoma by Monica H. Xing, Mykayla L. Sandler, R. Michael Tuttle, Azita Khorsandi, Shabnam Samankan, Neil Mundi, Mark L. Urken

Get full text

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for r... by Luis Felipe Zavala, María Inés Barra, Roberto Olmos, Michael Tuttle, Hernán González, Nicolás Droppelmann, Lorena Mosso, José M. Domínguez

Get full text

Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy by Irini Youssef, MD, Jennifer Yoon, MD, Nader Mohamed, BA, Kaveh Zakeri, MD, Robert H. Press, MD, Yao Yu, MD, Jung Julie Kang, MD, PhD, Richard J. Wong, MD, R. Michael Tuttle, MD, Ashok Shaha, MD, Eric Sherman, MD, Nancy Y. Lee, MD

Get full text